濮阳东方妇科很靠谱濮阳东方妇科医院做人流评价,濮阳东方医院治早泄收费正规,濮阳东方医院看妇科评价比较好,濮阳东方妇科收费比较低,濮阳东方男科好挂号吗,濮阳东方医院看男科病非常便宜,濮阳东方医院妇科看病便宜吗

A shipment of jalape?os from Mexico to the US proved to be carrying more than just a spicy kick when Border Patrol agents found nearly 4 tons of marijuana hidden in the cargo.The discovery was made Thursday when a truck driver was flagged for a secondary inspection at the Otay Mesa border crossing in California.During the inspection, a K-9 team alerted officers to the peppers, according to a press release 421

A Missouri city official is apologizing after an employee took two selfies of grinning police officers near where a baby's body was found this week in Columbia.The incident happened Thursday when Columbia Police Department officers were called to the scene in a wooded area. The infant 298

A team of St. Lucie County firefighters went above and beyond to help an elderly man in need.According to the St. Lucie County Fire District, Lt. John King, Justin Harnage, and Jeremy Rouse responded to a home on in Fort Pierce, Florida, on Tuesday after an 86-year-old man fell and was unable to get up.Officials said the elderly man has trouble walking and needed help getting into his wheelchair, which was located outside on the patio.Noticing that the home didn't have a proper wheelchair ramp, the three firefighters went back to their fire station, built a wheelchair ramp out of plywood, then took it back to the elderly man's home and installed it at his front door."Acts like these, which are above and beyond the call of duty, reinforce the Fire District motto: 'Our Family Serving Yours.'" said Division Chief Aaron Shaw. 845

A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history’s deadliest and most stubborn of diseases.The southern African nation is rolling out the shots in an unusual pilot program along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it’s worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa.Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with a howl.“I’m very excited about this,” said her mother, Esther Gonjani, who herself gets malaria’s aches, chills and fever at least once a year and loses a week of field work when one of her children is ill. “They explained it wasn’t perfect, but I feel secure it will relieve the pain.”There is little escaping malaria -- “malungo” in the local Chichewa language -- especially during the five-month rainy season. Stagnant puddles, where mosquitoes breed, surround the homes of brick and thatch and line the dirt roads through tea plantations or fields of maize and sugar cane. In the village of Tomali, the nearest health clinic is a two-hour bike ride away. The longer it takes to get care, the more dangerous malaria can be. Teams from the clinic offer basic medical care during visits once or twice a month, bringing the malaria shot and other vaccines in portable coolers. Treating malaria takes up a good portion of their time during the rainy season, according to Daisy Chikonde, a local health worker.“If this vaccine works, it will reduce the burden,” she said.Resident Doriga Ephrem proudly said her 5-month-old daughter, Grace, didn’t cry when she got the malaria shot.When she heard about the vaccine, Ephrem said her first thought was “protection is here.” Health workers explained, however, that the vaccine is not meant to replace antimalarial drugs or the insecticide-treated bed net she unfolds every night as the sun sets and mosquitoes rise from the shadows. “We even take our evening meals inside the net to avoid mosquitoes,” she said.It took three decades of research to develop the new vaccine, which works against the most common and deadly of the five parasite species that cause malaria. The parasite’s complex life cycle is a huge challenge. It changes forms in different stages of infection and is far harder to target than germs.“We don’t have any vaccines against parasites in routine use. This is uncharted territory,” said Ashley Birkett, who directs PATH’s Malaria Vaccine Initiative, a nonprofit that helped drugmaker GlaxoSmithKline develop the shot, brand-named Mosquirix. The bite of an infected mosquito sends immature parasites called sporozoites into the bloodstream. If they reach the liver, they’ll mature and multiply before spewing back into the blood to cause malaria’s debilitating symptoms. At that point, treatment requires medicines that kill the parasites.Mosquirix uses a piece of the parasite — a protein found only on sporozoites’ surface — in hopes of blocking the liver stage of infection. When a vaccinated child is bitten, the immune system should recognize the parasite and start making antibodies against it.Scientists also are searching for next-generation alternatives. In the pipeline is an experimental vaccine made of whole malaria parasites dissected from mosquitoes’ salivary glands but weakened so they won’t make people sick. Sanaria Inc. has been testing its vaccine in adults, and is planning a large, late-stage study in Equatorial Guinea’s Bioko Island.And the U.S. National Institutes of Health soon will start initial tests of whether injecting people periodically with lab-made antibodies, rather than depending on the immune system to make them, could offer temporary protection during malaria season. Think of them as “potentially short-term vaccines,” NIH’s Dr. Robert Seder told a recent meeting of the American Society of Tropical Medicine and Hygiene.For now, only babies in parts of Malawi, Kenya and Ghana are eligible for the Mosquirix vaccine. After the vaccine was approved in 2015, the World Health Organization said it first wanted a pilot roll-out to see how well it worked in a few countries — in real-world conditions — before recommending that the vaccine be given more widely across Africa. “Everyone is looking forward to getting it,” said Temwa Mzengeza, who oversees Malawi’s vaccine programs. Those eager for the shots include her husband, whom she had to stop from trying to get them, she said.Mzengeza used to come down with malaria several times a year until she started following her own advice to sleep under a net every night. Unlike many other kinds of infections, people can get malaria repeatedly, building up only a partial immunity.In the pilot program that began last year, 360,000 children in the three countries are meant to be vaccinated annually. The first dose is given at about age 5 months and the final, fourth booster near the child’s second birthday.Experts say it is too early to know how well the vaccine is working. They’re watching for malaria deaths, severe infections and cases of meningitis, something reported during studies but not definitively linked to the vaccine.“To do something completely new for malaria is exciting,” said researcher Don Mathanga, who is leading the evaluation in Malawi. The rainy season has brought new challenges, making some rural roads impassable and complicating efforts to track down children due for a shot. So far in Malawi, the first dose reached about half of the children targeted, about 35,000. That dropped to 26,000 for the second dose and 20,000 for the third. That’s not surprising for a new vaccine, Mzengeza said. “It will pick up with time.”At the health clinic in Migowi in Malawi’s southern highlands, workers see signs of hope. Henry Kadzuwa explains the vaccine to mothers waiting at the clinic. He said there was a drop in malaria cases to 40 in the first five months of the program, compared to 78 in the same period in 2018.Even though he wishes his 3-year-old daughter, Angel, could receive the vaccine, “it’s protecting my community. It also makes my work easier,” Kadzuwa said. The Migowi area has one of the country’s highest rates of malaria, and a worn paper register in the clinic’s laboratory lists scores of cases.At the clinic, Agnes Ngubale said she had malaria several years ago and wants to protect her 6-month-old daughter, Lydia, from the disease.“I want her to be healthy and free,” she said. “I want her to be a doctor.”And she has memorized the time for Lydia’s second dose: “Next month, same date.”___Neergaard reported from Washington.___The Associated Press Health and Science Department receives 7200

America's Dairyland is in crisis. More and more Wisconsin dairy farmers are going out of business. Part of the solution might actually involve milk — but not in the way one might think.About 700 Wisconsin Dairy farms went out of business last year — more than two each day."The dairy industry has been struggling for a while, but now the problem has become acute and we must act and we must act now," said Wayne Weber, Dean of the College of Business, Industry, Life Science, and Agriculture at University of Wisconsin-Platteville.That action starts at a farm tucked away in the rolling hills of Southwest Wisconsin. Professor Tera Montgomery helps run the Pioneer Farm at UW-Platteville. The cows and calves are part of her classroom."It's a living and learning laboratory so there is something going on all the time," Montgomery said. "It's a working farm."Platteville is one of three UW schools hoping to get a share of million in research dollars from the state to start the first ever Dairy Innovation Hub — a center dedicated to tasks like finding new dairy products, but also looking for unconventional ways to use milk.One of those techniques involves combining manure and cheese byproducts in a digester, creating energy. Montgomery says that this energy could potentially run communities local to dairy farms.Students at the Pioneer Farm are also hoping to develop new products to help people with allergies or an intolerance to milk enjoy it."It's making sure we are making unique products that are going to be what the consumer wants and what the consumer needs," Montgomery said.It's not just about finding ways to produce more milk. Weber believes the research dollars will produce results for an industry that already contributes billion to Wisconsin's economy."It's going to provide an infrastructure by which we can work with, together, industry partners - researchers, to start to deal with those questions on how do we move the dairy industry into a positive and viable industry in the future," he said.Not only for America's Dairyland, but for America.The research money for the Dairy Innovation Hub made it out of the Senate Committee on Agriculture, Revenue and Financial Institutions with a unanimous vote. It still needs to clear the Senate and Assembly before getting to the desk of Wisconsin Governor Tony Ever. 2356